Cargando…

Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS and Oesophagectomy

Enhanced Recovery After Surgery (ERAS) protocols are widely used in oesophageal cancer surgery. Multiple studies have demonstrated that ERAS protocols are associated with a shorter length of stay and a reduction in the incidence of post-operative complications after oesophagectomy. However, there is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moorthy, Krishna, Halliday, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Gastrointestinal Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677631/ https://www.ncbi.nlm.nih.gov/pubmed/34668118 http://dx.doi.org/10.1245/s10434-021-10384-5

Ejemplares similares

Research Priorities in Prehabilitation for Patients Undergoing Cancer Surgery: An International Delphi Study
por: Raichurkar, Pratik, et al.
Publicado: (2023)

Failure to Cure in Patients Undergoing Surgery for Gastric Cancer: A Nationwide Cohort Study
por: Voeten, Daan M., et al.
Publicado: (2021)

Enhanced Recovery After Surgery can Improve Patient Outcomes and Reduce Hospital Cost of Gastrectomy for Cancer in the West: A Propensity-Score-Based Analysis
por: Weindelmayer, Jacopo, et al.
Publicado: (2021)

Preoperative Cardiopulmonary Exercise Test Associated with Postoperative Outcomes in Patients Undergoing Cancer Surgery: A Systematic Review and Meta-Analyses
por: Steffens, Daniel, et al.
Publicado: (2021)

Is There a Place for Esogastric Cancer Surgery in Cirrhotic Patients?
por: Mariette, Christophe
Publicado: (2008)

A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study
por: Brenkman, Hylke J. F., et al.
Publicado: (2017)

Surgery for Esophageal Cancer: Quality of Life Matters
por: Salo, Jonathan C
Publicado: (2009)

Disparities in Utilization and Outcomes of Minimally Invasive Techniques for Gastric Cancer Surgery in the United States
por: Park, Joon Y., et al.
Publicado: (2022)

The Cancer Hub Approach for Upper Gastrointestinal Surgery During COVID-19 Pandemic: Outcomes from a UK Cancer Centre
por: Doyle, Joseph P., et al.
Publicado: (2022)

Surgeon Volume and Surgeon Age in Relation to Proficiency Gain Curves for Prognosis Following Surgery for Esophageal Cancer
por: Gottlieb-Vedi, Eivind, et al.
Publicado: (2018)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
por: Yang, Xiao-Jun, et al.
Publicado: (2011)

Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS)
por: Toxopeus, Eelke, et al.
Publicado: (2018)

Surgery for Gastric Remnant Cancer Results in Similar Overall Survival Rates Compared with Primary Gastric Cancer: A Propensity Score-Matched Analysis
por: Galata, Christian, et al.
Publicado: (2020)

Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study
por: Borgstein, Alexander B. J., et al.
Publicado: (2021)

Is Re-introducing Major Open and Minimally Invasive Surgery during COVID-19 Safe for Patients and Healthcare Workers? An International, Multi-centre Cohort Study in the Field of Oesophago-gastric Surgery
por: Alasmar, Mohamed, et al.
Publicado: (2021)

Imaging for Quality Control: Comparison of Systematic Video Recording to the Operative Note in Colorectal Cancer Surgery. A Pilot Study
por: van de Graaf, F. W., et al.
Publicado: (2016)

Sarcopenia and Comorbidity in Gastric Cancer Surgery as a Useful Combined Factor to Predict Eventual Death from Other Causes
por: Kuwada, Kazuya, et al.
Publicado: (2018)

Understanding Potentially Preventable Mortality Following Oesophago-Gastric Cancer Surgery: Analysis of a National Audit of Surgical Mortality
por: Liu, David S., et al.
Publicado: (2023)

Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery
por: Hentzen, Judith E. K. R., et al.
Publicado: (2019)

Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
por: Bjersand, Kathrine, et al.
Publicado: (2015)

Induced Bias Due to Crossover Within Randomized Controlled Trials in Surgical Oncology: A Meta-regression Analysis of Minimally Invasive versus Open Surgery for the Treatment of Gastrointestinal Cancer
por: Garas, George, et al.
Publicado: (2017)

Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery
por: Mavros, Michail N., et al.
Publicado: (2023)

Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
por: Takeuchi, Hiroya, et al.
Publicado: (2010)

Surgical Margins during Hepatic Surgery for Colorectal Liver Metastases: Complete Resection not Millimeters Defines Outcome
por: Pawlik, Timothy M., et al.
Publicado: (2007)

Is there a Benefit of Multidisciplinary Cancer Team Meetings for Patients with Gastrointestinal Malignancies?
por: Basta, Yara L., et al.
Publicado: (2016)

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
por: Omloo, J. M. T., et al.
Publicado: (2011)

A Population-based Study on Lymph Node Retrieval in Patients with Esophageal Cancer: Results from the Dutch Upper Gastrointestinal Cancer Audit
por: van der Werf, L. R., et al.
Publicado: (2018)

Non- or full-laxative CT colonography vs. endoscopic tests for colorectal cancer screening: A randomised survey comparing public perceptions and intentions to undergo testing
por: Ghanouni, Alex, et al.
Publicado: (2014)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience
por: Liu, Yang, et al.
Publicado: (2018)

Prevalence and Prognostic Significance of Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer
por: Faiz, Zohra, et al.
Publicado: (2018)

Prognostic Value of Postoperative CEA Clearance in Rectal Cancer Patients with High Preoperative CEA Levels
por: Kim, Jeong Yeon, et al.
Publicado: (2009)

Population-Based Study on Risk Factors for Tumor-Positive Resection Margins in Patients with Gastric Cancer
por: van der Werf, Leonie R., et al.
Publicado: (2019)

A Population-Based Analysis of Three Treatment Modalities for Malignant Obstruction of the Proximal Colon: Acute Resection Versus Stent or Stoma as a Bridge to Surgery
por: Amelung, F. J., et al.
Publicado: (2016)

Extended Esophagectomy in Elderly Patients with Esophageal Cancer: Minor Effect of Age Alone in Determining the Postoperative Course and Survival
por: Pultrum, B. B., et al.
Publicado: (2010)

Association Among Blood Transfusion, Postoperative Infectious Complications, and Cancer-Specific Survival in Patients with Stage II/III Gastric Cancer After Radical Gastrectomy: Emphasizing Benefit from Adjuvant Chemotherapy
por: Xiao, Hua, et al.
Publicado: (2020)

A High Body Mass Index in Esophageal Cancer Patients Does Not Influence Postoperative Outcome or Long-Term Survival
por: Blom, R. L. G. M., et al.
Publicado: (2011)

Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer
por: Rombouts, Steffi J., et al.
Publicado: (2016)

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
por: Katz, Matthew H. G., et al.
Publicado: (2010)

Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study
por: Hentzen, Judith E. K. R., et al.
Publicado: (2019)

Radical Resection After IORT-Containing Multimodality Treatment is the Most Important Determinant for Outcome in Patients Treated for Locally Recurrent Rectal Cancer
por: Dresen, Raphaëla C., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9kvk86ljgv8oedsi9721kvdj1e